Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:34 AM
Ignite Modification Date:
2025-12-25 @ 2:34 AM
NCT ID:
NCT00245934
Eligibility Criteria:
Inclusion Criteria:
* Proven diagnosis of rheumatoid arthritis
Exclusion Criteria:
* Contraindications according to Summary of Product Characteristic (SmPC)of Enbrel® the following points will prevent or restrict participation:
* Patients who suffer from hypersensitivity to the active substance Etanercept or to any of the excipients of Enbrel®
* Treatment with Enbrel® should not be initiated in patients with active infections including chronic or localized infections
* Patients with sepsis or risk of sepsis should not be treated
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00245934
Study Brief:
Protocol Section:
NCT00245934